RU94040387A - Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака - Google Patents

Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака

Info

Publication number
RU94040387A
RU94040387A RU94040387/14A RU94040387A RU94040387A RU 94040387 A RU94040387 A RU 94040387A RU 94040387/14 A RU94040387/14 A RU 94040387/14A RU 94040387 A RU94040387 A RU 94040387A RU 94040387 A RU94040387 A RU 94040387A
Authority
RU
Russia
Prior art keywords
nicotine
containing composition
smoking
tobacco
substitute
Prior art date
Application number
RU94040387/14A
Other languages
English (en)
Other versions
RU2118897C1 (ru
Inventor
Л.Джонс Ричард
Ca]
Original Assignee
Дзе Гавернэс Оф Дзе Юниверсити Оф Альберта (Ca)
Дзе Гавернэс оф дзе Юниверсити оф Альберта
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Гавернэс Оф Дзе Юниверсити Оф Альберта (Ca), Дзе Гавернэс оф дзе Юниверсити оф Альберта filed Critical Дзе Гавернэс Оф Дзе Юниверсити Оф Альберта (Ca)
Publication of RU94040387A publication Critical patent/RU94040387A/ru
Application granted granted Critical
Publication of RU2118897C1 publication Critical patent/RU2118897C1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Предложена никотиносодержащая композиция для назального приема для содействия снижению потребности человека в курении табака или для предоставления заменителя курения табака.

Claims (1)

  1. Предложена никотиносодержащая композиция для назального приема для содействия снижению потребности человека в курении табака или для предоставления заменителя курения табака.
RU94040387A 1992-01-03 1993-01-04 Композиция, способствующая прекращению курения, способ снижения потребности в курении табака (варианты), способ замены курения табака (варианты) RU2118897C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929200047A GB9200047D0 (en) 1992-01-03 1992-01-03 Nicotine-containing nasal spray
GB9200047.0 1992-01-03

Publications (2)

Publication Number Publication Date
RU94040387A true RU94040387A (ru) 1996-10-20
RU2118897C1 RU2118897C1 (ru) 1998-09-20

Family

ID=10708064

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94040387A RU2118897C1 (ru) 1992-01-03 1993-01-04 Композиция, способствующая прекращению курения, способ снижения потребности в курении табака (варианты), способ замены курения табака (варианты)

Country Status (21)

Country Link
US (1) US5656255A (ru)
EP (1) EP0619729B1 (ru)
JP (1) JP3830158B2 (ru)
KR (2) KR100317426B1 (ru)
AT (1) ATE182070T1 (ru)
AU (1) AU664415B2 (ru)
CA (1) CA2127253C (ru)
CZ (1) CZ294555B6 (ru)
DE (1) DE69325643T2 (ru)
DK (1) DK0619729T3 (ru)
ES (1) ES2135460T3 (ru)
FI (1) FI111049B (ru)
GB (1) GB9200047D0 (ru)
GR (1) GR3031075T3 (ru)
HU (1) HUT73247A (ru)
NO (1) NO308123B1 (ru)
NZ (1) NZ246533A (ru)
RU (1) RU2118897C1 (ru)
SK (1) SK282336B6 (ru)
UA (1) UA37201C2 (ru)
WO (1) WO1993012764A1 (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011087393A1 (ru) * 2010-01-18 2011-07-21 Общество С Ограниченной Ответственностью "Вегавольт" Композиция растительного происхождения, предназначенная для вдыхания дыма, образующегося при ее сжигании

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
JPH11507810A (ja) * 1995-06-05 1999-07-13 ヒューマン ジノーム サイエンシーズ，インコーポレイテッド Ｇタンパク質副甲状腺ホルモンレセプターｈｌｔｄｇ７４
CA2231968A1 (en) * 1998-03-11 1999-09-11 Smoke-Stop, A Partnership Consisting Of Art Slutsky Method of producing a nicotine medicament
GB9806937D0 (en) 1998-03-31 1998-05-27 Procter & Gamble A spray device
US6596740B2 (en) 2000-10-24 2003-07-22 Richard L. Jones Nicotine mucosal spray
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
DE60105820D1 (de) * 2001-10-22 2004-10-28 Pera Ivo E Zusammensetzung zur Reduzierung oder Entwöhnung von Nikotinabhängigkeit
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
US20030171408A1 (en) * 2002-03-11 2003-09-11 Caplan Jay L. Therapeutic method of delivering a medicament to avoid irritating effects on membranes of user
US7767698B2 (en) 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
SE0201669D0 (sv) * 2002-06-03 2002-06-03 Pharmacia Ab New formulation and use thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
DK1578422T3 (da) * 2002-12-20 2007-07-02 Niconovum Ab Fysisk og kemisk stabilt nikotin-indeholdende partikelholdigt materiale
ATE510174T1 (de) 2003-05-21 2011-06-15 Alexza Pharmaceuticals Inc Schlag gezündete unabhängige heizeinheit
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US7766018B2 (en) * 2004-09-30 2010-08-03 Smoke-Break, Inc. Device and composition for reducing the incidence of tobacco smoking
US8322350B2 (en) 2004-12-30 2012-12-04 Philip Morris Usa Inc. Aerosol generator
US8323683B2 (en) 2005-05-18 2012-12-04 Mcneil-Ppc, Inc. Flavoring of drug-containing chewing gums
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
CA2682323A1 (en) * 2007-04-02 2008-10-09 Parkinson's Institute Methods and compositions for reduction of side effects of therapeutic treatments
EP2218760B1 (en) * 2007-11-30 2015-09-02 Japan Tobacco Inc. Aerosol-generating solution for aerosol aspirator
EP2233134A1 (en) 2009-03-27 2010-09-29 McNeil AB Multi-portion intra-oral dosage form with organoleptic properties
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
CA2841785A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
CA2974324A1 (en) 2015-01-28 2016-08-04 Zita S. Netzel Drug delivery methods and systems
EP3267875A4 (en) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Craving input and support system
US10532046B2 (en) 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
AU2017228051B2 (en) * 2016-02-29 2022-06-23 Nicogen Ltd. Nicotine formulation and aerosols
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
SE541358C2 (en) 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
AU2019279884A1 (en) 2018-05-29 2020-12-10 Morningside Venture Investments Limited Drug delivery methods and systems
EP3807260B1 (en) 2018-06-15 2024-09-18 R. J. Reynolds Tobacco Company Purification of nicotine
CZ309558B6 (cs) * 2021-05-25 2023-04-12 Consumer Brands International s.r.o. Náplň nikotinového prostředku, zejména nikotinového sáčku a způsob jeho výroby

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2030862A (en) * 1978-04-10 1980-04-16 Smith A A composition for treating drug addiction such as smoking nicotine-containing products
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
GB2133691B (en) * 1983-01-21 1986-05-21 Leo Ab Smoking substitutes for nasal administration
US4953572A (en) * 1985-04-25 1990-09-04 Rose Jed E Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4920989A (en) * 1985-04-25 1990-05-01 Regents Of The University Of California Method and apparatus for aiding in the reduction of incidence of tobacco smoking
US4715387A (en) * 1985-08-23 1987-12-29 The Regents Of The Univ. Of California Aerosol for use in the reduction of tobacco smoking
SE8601351D0 (sv) * 1986-03-24 1986-03-24 Nilsson Sven Erik Styrd administration av fysiologiskt aktiva emnen
GB8614805D0 (en) * 1986-06-18 1986-07-23 British American Tobacco Co Aerosol device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011087393A1 (ru) * 2010-01-18 2011-07-21 Общество С Ограниченной Ответственностью "Вегавольт" Композиция растительного происхождения, предназначенная для вдыхания дыма, образующегося при ее сжигании

Also Published As

Publication number Publication date
NO942502D0 (no) 1994-07-01
DK0619729T3 (da) 2000-04-17
EP0619729A1 (en) 1994-10-19
ATE182070T1 (de) 1999-07-15
FI111049B (fi) 2003-05-30
HUT73247A (en) 1996-07-29
ES2135460T3 (es) 1999-11-01
AU664415B2 (en) 1995-11-16
CZ294555B6 (cs) 2005-02-16
CZ160894A3 (en) 1995-09-13
RU2118897C1 (ru) 1998-09-20
SK79694A3 (en) 1995-06-07
US5656255A (en) 1997-08-12
KR950700055A (ko) 1995-01-16
JP3830158B2 (ja) 2006-10-04
EP0619729B1 (en) 1999-07-14
NO942502L (no) 1994-09-02
KR100317426B1 (ru) 2001-11-30
CA2127253C (en) 1999-09-21
FI943173A (fi) 1994-09-01
GR3031075T3 (en) 1999-12-31
UA37201C2 (ru) 2001-05-15
NZ246533A (en) 1996-04-26
DE69325643T2 (de) 2000-02-10
HU9402003D0 (en) 1994-09-28
CA2127253A1 (en) 1993-07-08
AU3340393A (en) 1993-07-28
WO1993012764A1 (en) 1993-07-08
JPH07504164A (ja) 1995-05-11
SK282336B6 (sk) 2002-01-07
FI943173A0 (fi) 1994-07-01
DE69325643D1 (de) 1999-08-19
NO308123B1 (no) 2000-07-31
GB9200047D0 (en) 1992-02-26

Similar Documents

Publication Publication Date Title
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
MD1813C2 (ru) Очищенные производные сульфоалкильных эфиров циклодекстрина или их смеси, клатратный комплекс производных циклодекстрина с лекарственным веществом и фармацевтическая композиция
AU1537095A (en) Therapeutic agents containing thyroid hormones
AU2506388A (en) Azelastine-containing medicaments for application in the nose and/or at the eye
CA2114014A1 (en) Advanced Drug Delivery System and Method of Treating Psychiatric, Neurological and Other Disorders with Carbamazepine
EP0552256A4 (ru)
AU599792B2 (en) Anti-parkinsonian indolone derivatives
FI955583A0 (fi) Nikotiinia sisältävä nasaalinen lääkkeenjakelukoostumus
SE8804629D0 (sv) New therapeutically active compounds
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
EP0513702A3 (en) Melatonin derivaties for use in the therapy of sleep disorders and in pre-anaesthetic medication
ATE77947T1 (de) Pentamidin enthaltende pharmazeutische zusammensetzungen.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
ATE388687T1 (de) Medikamentöse verabreichung von nikotin in form von kaugummi
ATE193442T1 (de) 3,4-diarylchromane zur behandlung von dermatitis
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
WO1993017691A3 (en) Pharmaceutical compositions containing monosialoganglioside gm1 or a derivative thereof suitable for the treatment of parkinson's disease
EE04330B1 (et) Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks
AU6432899A (en) Use of metformin to counteract weight gain associated with valproate and other psychotropic medications
RU94040242A (ru) Способ лечения туберкулеза
RO102780B1 (ro) Metoda de anestezie generala
MY124346A (en) Medicated chewing gum delivery system for nicotine
JO1531B1 (en) New near-compounds
MX9709872A (es) Formulaciones novedosas para suministro transdermico de pergolide.

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
PC4A Invention patent assignment

Effective date: 20100302